- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Marksans Pharma Limited — Updates, 15-05-2025: Press Release
15-05-2025 | 09:24 am
15-05-2025 | 09:24 am
Marksans Pharma’s UK arm, Relonchem Limited, secured marketing approval for Gabapentin 50 mg/ml oral solution, bolstering its CNS portfolio. This move enhances the company’s foothold in the UK market and is expected to drive future revenue growth through innovative generics in regulated markets.
No comments yet. Be the first to comment!